GlobeNewswire by notified

Norsk Hydro: Status share buyback program


Please see below information about transactions made under the share buy-back program for Norsk Hydro ASA.

Announcement date of the share buyback program: September 23, 2022

End date of the share buyback program: March 29, 2023

Overview of transactions:

Date Aggregate daily volume (no. of shares) Volume weighted average price (NOK) Total transaction value (NOK)
26.09.2022177 00055.919 895 238
27.09.2022170 00057.779 820 305
28.09.2022178 00055.879 945 447
29.09.2022170 00057.679 803 526
30.09.2022170 00058.539 950 746
Total transactions under the program:865 00057.1349 415 263

Following the above listed transactions, Norsk Hydro ASA owns a total of 17 317 403 shares, corresponding to 0.84% of Norsk Hydro ASA's share capital.

Attachment: An overview of all the completed transactions under the program for the dates specified above is attached to this notification and available on

This is information that Norsk Hydro ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Investor contact:
Line Haugetraa
Head of Investor Relations
+47 41406376


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab)9.12.2022 13:30:00 CET | Press release

CAMBRIDGE, Mass., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB800, a biosimilar candidate referencing ACTEMRA®1 (tocilizumab), an anti-interleukin-6 receptor monoclonal antibody. ACTEMRA® is indicated for several indications, including moderate to severe rheumatoid arthritis in adults as well as juvenile idiopathic polyarthritis and systemic juvenile idiopathic arthritis. “The FDA filing is supported by Phase 3 data from a comparative clinical trial demonstrating equivalent efficacy and a comparable safety and immunogenicity profile to the reference product,” said Ian Henshaw, Head of Global Biosimilars at Biogen. “We look forward to working with regulators to bring this potential treatment option for people with immune mediated inflammatory diseases.” As previously reported, positive Phase 32 data for BIIB800 up to week 24 w

BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds9.12.2022 13:15:00 CET | Press release

BBS-Bioactive Bone Substitutes Oyj, Company Announcement, 9 December 2022 at 2.15 p.m. EET BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds The subscription period for BBS-Bioactive Bone Substitutes Oyj's first series of warrants 1-2022 (WA1) ended on 2 December 2022. In total, 231,415 warrants 1-2022 (WA1) were used, corresponding to approximately 69.0 percent of the total number of warrants. BBS-Bioactive Bone Substitutes Oyj received approximately EUR 213 000 in gross proceeds before expenses. The company's Board of Directors has today approved the share subscriptions. The subscription price was EUR 0.92 and SEK 10.10 per share. The subscription period for the shares was 21 November – 2 December 2022. The shares are expected to be registered in the trade register on 16 December 2022 and trading is estimated to begin on 19 December 2022. The warrants which were not used to subscribe to t

Finanskalender 2023 for Investeringsforeningen Handelsinvest9.12.2022 13:08:35 CET | pressemeddelelse

Investeringsforeningen Handelsinvest Østergade 2 7400 Herning Tlf. 9712 3355 Nasdaq Copenhagen A/S Nikolaj Plads 6 1007 København K9. december 2022 Finanskalender 2023 for Investeringsforeningen Handelsinvest Forventede datoer er vedtaget for offentliggørelse af regnskabsmeddelelser og afholdelse af ordinær generalforsamling: DatoMeddelelsestype21. februar 2023Årsrapport 20229. marts 2023Ordinær generalforsamling24. august 2023Halvårsrapport 01.01 – 30.06.2023 Yderligere oplysninger kan fås ved henvendelse til administrerende direktør Henrik Kragh, tlf. nr. 9992 0130.

Clean Motion signs distribution agreement for Italy with X-Raam Srl.9.12.2022 13:05:44 CET | Press release

Clean Motion has signed a four-year-long distribution agreement with X-RaamSrl. for the Italian market. The agreement refers to EVIG, Clean Motion's new electric delivery vehicle. This means that X-Raam is responsible for sales, distribution, and aftermarket in Italy. The distributor's sales forecast for next year is 200 vehicles, but it only commits to a volume of 50 vehicles. For the entire contract period, 2023-2026, they commit to 650 vehicles. The electric vehicle distributor X-Raam, with a dealer network in Italy, now has EVIG in its portfolio. X-Raam has a forecast of 200 vehicles as early as 2023 and has therefore signed a 4-year-long distribution agreement for EVIG. As part of this, X-Raam has committed to purchase at least 50 EVIG in 2023 and 600 EVIG in 2024–2026. Alberto Fiorini, General Manager at X-Raam, “Growth expectations for urban mobility in the coming years are high, especially for commercial electric vehicles for last mile deliveries. With its performance, technolo

Clean Motion tecknar distributionsavtal för Italien med X-Raam Srl.9.12.2022 13:05:44 CET | Pressemelding

Clean Motion har tecknat ett 4-årigt distributionsavtal med X-Raam Srl. för den italienska marknaden. Avtalet avser EVIG, Clean Motions nya elektriska leveransfordon. Det innebär att X-Raam ansvarar för försäljning, distribution och eftermarknad i Italien. Distributörens försäljningsprognos för nästa år är 200 fordon, men man förbinder sig endast till en volym på 50 fordon. För hela avtalsperioden, 2023-2026, förbinder man sig till 650 fordon. Elfordonsdistributören X-Raam, med återförsäljarnätverk i Italien, har nu även EVIG i portföljen. X-Raam har en prognos på 200 fordon redan under 2023, och har därför tecknat ett 4-årigt distributionsavtal för EVIG. Som en del av detta har X-Raam åtagit sig att köpa minst 50st EVIG under 2023 och 600st EVIG 2024–2026. Alberto Fiorini, General Manager på X-Raam, ”Tillväxtförväntningar för stadsmobilitet under de kommande åren är stora, särskilt när det gäller kommersiella elfordon för sista milen-leveranser. EVIG har med sin prestanda, sin teknik